STIC

Pharma Sector

The pharmaceutical industry in Thailand and ASEAN is entering a golden era, fueled by an aging population, rising incomes, expanded healthcare coverage, and strong government support for medical innovation. Thailand’s strategic initiatives like the “Thailand 4.0” economic model prioritize becoming a medical hub for Asia, with major investments in pharmaceutical manufacturing, biotech, and research and development. ASEAN’s combined market offers a population of over 650 million, creating vast demand for medicines, vaccines, and healthcare solutions. For foreign businesses, this is the perfect time to enter — whether through manufacturing, R&D collaborations, or distribution. However, navigating regulatory approvals, intellectual property protections, and local partnerships is critical for success. STIC’s team brings deep industry insight, strong local networks, and regulatory expertise to help foreign pharma companies thrive. Whether you're looking to set up production facilities, clinical research units, or regional headquarters, STIC ensures you hit the ground running in Southeast Asia’s vibrant pharma market.